Literature DB >> 20418072

Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers.

Scott C Matthews1, Alan N Simmons, Irina A Strigo, Estibaliz Arce, Murray B Stein, Martin P Paulus.   

Abstract

Medial cortex is critically involved in self-referential processing. Little is known about how selective serotonin reuptake inhibitors (SSRIs) affect medial cortical activity during self-assessment. We hypothesized that a 3-week oral course of escitalopram,10 mg/day, would alter activity related to self-referential processing in medial cortex. Fifteen healthy females performed a self-assessment task during functional magnetic resonance imaging on two occasions--once after 3 weeks of placebo and once at the end of 3 weeks of escitalopram. Task conditions involved responding "yes" or "no" to whether various positive and negative adjectives described the subject (i.e., "self" evaluation trials) or the subject's best friend (i.e., "other" evaluation trials), whereas the comparison condition involved responding whether the valence of various adjectives was positive or negative (i.e., "word" evaluation trials). Behaviorally after escitalopram, subjects less frequently endorsed that negative adjectives described themselves. Three main neuroimaging results were observed: (1) increased activation in medial prefrontal cortex and posterior cingulate related to self minus word evaluation trials, (2) increased activation in posterior cingulate related to escitalopram minus placebo for self and word evaluation trials, and (3) drug by task interactions in the insula, cerebellum and prefrontal cortex. These results show that SSRIs change medial cortical activity and may alter self-evaluation. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418072      PMCID: PMC2882791          DOI: 10.1016/j.pscychresns.2010.02.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  45 in total

1.  Cortical networks for working memory and executive functions sustain the conscious resting state in man.

Authors:  B Mazoyer; L Zago; E Mellet; S Bricogne; O Etard; O Houdé; F Crivello; M Joliot; L Petit; N Tzourio-Mazoyer
Journal:  Brain Res Bull       Date:  2001-02       Impact factor: 4.077

Review 2.  The anatomical connections of the macaque monkey orbitofrontal cortex. A review.

Authors:  C Cavada; T Compañy; J Tejedor; R J Cruz-Rizzolo; F Reinoso-Suárez
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

3.  A default mode of brain function.

Authors:  M E Raichle; A M MacLeod; A Z Snyder; W J Powers; D A Gusnard; G L Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

4.  Stress and selective attention: the interplay of mood, cortisol levels, and emotional information processing.

Authors:  Mark A Ellenbogen; Alex E Schwartzman; Jane Stewart; Claire-Dominique Walker
Journal:  Psychophysiology       Date:  2002-11       Impact factor: 4.016

5.  Dissociation of inhibition from error processing using a parametric inhibitory task during functional magnetic resonance imaging.

Authors:  Scott C Matthews; Alan N Simmons; Estibaliz Arce; Martin P Paulus
Journal:  Neuroreport       Date:  2005-05-12       Impact factor: 1.837

6.  Self-referential processing in our brain--a meta-analysis of imaging studies on the self.

Authors:  Georg Northoff; Alexander Heinzel; Moritz de Greck; Felix Bermpohl; Henrik Dobrowolny; Jaak Panksepp
Journal:  Neuroimage       Date:  2006-02-07       Impact factor: 6.556

7.  Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals.

Authors:  Greg J Siegle; Stuart R Steinhauer; Michael E Thase; V Andrew Stenger; Cameron S Carter
Journal:  Biol Psychiatry       Date:  2002-05-01       Impact factor: 13.382

8.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

Authors:  S H Kennedy; K R Evans; S Krüger; H S Mayberg; J H Meyer; S McCann; A I Arifuzzman; S Houle; F J Vaccarino
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

Review 9.  Searching for a baseline: functional imaging and the resting human brain.

Authors:  D A Gusnard; M E Raichle; M E Raichle
Journal:  Nat Rev Neurosci       Date:  2001-10       Impact factor: 34.870

10.  Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity.

Authors:  Shinpei Yoshimura; Yasumasa Okamoto; Keiichi Onoda; Miki Matsunaga; Kazutaka Ueda; Shin-ichi Suzuki
Journal:  J Affect Disord       Date:  2009-07-09       Impact factor: 4.839

View more
  9 in total

1.  Differential modulation of the default mode network via serotonin-1A receptors.

Authors:  Andreas Hahn; Wolfgang Wadsak; Christian Windischberger; Pia Baldinger; Anna S Höflich; Jan Losak; Lukas Nics; Cécile Philippe; Georg S Kranz; Christoph Kraus; Markus Mitterhauser; Georgios Karanikas; Siegfried Kasper; Rupert Lanzenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Antidepressants normalize the default mode network in patients with dysthymia.

Authors:  Jonathan Posner; David J Hellerstein; Inbal Gat; Anna Mechling; Kristin Klahr; Zhishun Wang; Patrick J McGrath; Jonathan W Stewart; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2013-04       Impact factor: 21.596

3.  Interaction of neuropeptide Y genotype and childhood emotional maltreatment on brain activity during emotional processing.

Authors:  Esther M Opmeer; Rudie Kortekaas; Marie-José van Tol; Nic J A van der Wee; Saskia Woudstra; Mark A van Buchem; Brenda W J H Penninx; Dick J Veltman; André Aleman
Journal:  Soc Cogn Affect Neurosci       Date:  2013-03-11       Impact factor: 3.436

4.  Relations between cortical thickness, serotonin 1A receptor binding, and structural connectivity: A multimodal imaging study.

Authors:  Rajapillai L I Pillai; Ashwin Malhotra; Deborah D Rupert; Bennett Weschler; John C Williams; Mengru Zhang; Jie Yang; J John Mann; Maria A Oquendo; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2017-11-27       Impact factor: 5.038

5.  Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.

Authors:  Lu Lu; Jeffrey A Mills; Hailong Li; Heidi K Schroeder; Sarah A Mossman; Sara T Varney; Kim M Cecil; Xiaoqi Huang; Qiyong Gong; Laura B Ramsey; Melissa P DelBello; John A Sweeney; Jeffrey R Strawn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-02-04       Impact factor: 13.113

Review 6.  Self-referential processing, rumination, and cortical midline structures in major depression.

Authors:  Ayna Baladi Nejad; Philippe Fossati; Cédric Lemogne
Journal:  Front Hum Neurosci       Date:  2013-10-10       Impact factor: 3.169

7.  Healthy individuals treated with clomipramine: an fMRI study of brain activity during autobiographical recall of emotions.

Authors:  C T Cerqueira; J R Sato; J R C de Almeida; E Amaro; C C Leite; C Gorenstein; V Gentil; G F Busatto
Journal:  Transl Psychiatry       Date:  2014-07-01       Impact factor: 6.222

8.  Cortical and Striatal Reward Processing in Parkinson's Disease Psychosis.

Authors:  Sara Garofalo; Azucena Justicia; Gonzalo Arrondo; Anna O Ermakova; Pranathi Ramachandra; Carina Tudor-Sfetea; Trevor W Robbins; Roger A Barker; Paul C Fletcher; Graham K Murray
Journal:  Front Neurol       Date:  2017-04-24       Impact factor: 4.003

9.  Frequency-Specific Changes in the Fractional Amplitude of the Low-Frequency Fluctuations in the Default Mode Network in Medication-Free Patients With Bipolar II Depression: A Longitudinal Functional MRI Study.

Authors:  Jun Zhou; Xiaoqian Ma; Chunwang Li; Aijun Liao; Zihao Yang; Honghong Ren; Jinsong Tang; Jinguang Li; Zongchang Li; Ying He; Xiaogang Chen
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.